sitagliptin grindeks 50 mg apvalkotās tabletes
grindeks, as, latvia - sitagliptīns - apvalkotā tablete - 50 mg
sitagliptin grindeks 100 mg apvalkotās tabletes
grindeks, as, latvia - sitagliptīns - apvalkotā tablete - 100 mg
sitagliptin sandoz 50 mg apvalkotās tabletes
sandoz pharmaceuticals d.d., slovenia - sitagliptīns - apvalkotā tablete - 50 mg
sitagliptin sandoz 100 mg apvalkotās tabletes
sandoz pharmaceuticals d.d., slovenia - sitagliptīns - apvalkotā tablete - 100 mg
sitagliptin sandoz 25 mg apvalkotās tabletes
sandoz pharmaceuticals d.d., slovenia - sitagliptīns - apvalkotā tablete - 25 mg
sitagliptin teva 100 mg apvalkotās tabletes
teva b.v., netherlands - sitagliptīns - apvalkotā tablete - 100 mg
sitagliptin wörwag pharma 25 mg apvalkotās tabletes
wörwag pharma gmbh & co.kg, germany - sitagliptīns - apvalkotā tablete - 25 mg
sitagliptin wörwag pharma 50 mg apvalkotās tabletes
wörwag pharma gmbh & co.kg, germany - sitagliptīns - apvalkotā tablete - 50 mg
sitagliptin wörwag pharma 100 mg apvalkotās tabletes
wörwag pharma gmbh & co.kg, germany - sitagliptīns - apvalkotā tablete - 100 mg
segluromet
merck sharp & dohme b.v. - ertugliflozin l-pyroglutamic acid, metformin hydrochloride - cukura diabēts, 2. tips - drugs used in diabetes, combinations of oral blood glucose lowering drugs - segluromet is indicated in adults aged 18 years and older with type 2 diabetes mellitus as an adjunct to diet and exercise to improve glycaemic control:in patients not adequately controlled on their maximally tolerated dose of metformin alonein patients on their maximally tolerated doses of metformin in addition to other medicinal products for the treatment of diabetesin patients already being treated with the combination of ertugliflozin and metformin as separate tablets.